New insights into salt-sensitive hypertension by Ziomber-Lisiak, Agata et al.
61FOLIA MEDICA CRACOVIENSIA
Vol. LII, 3–4, 2012: 61–66 
PL ISSN 0015-5616
AgAtA Ziomber, KAjetAn jusZcZAK, Piotr thor
NEW INSIGHTS INTO SALT-SENSITIVE HYPERTENSION
Abstract: New insights into salt-sensitive hypertension
Salt sensitivity, described as association between salt intake and blood pressure, varies among indi-
viduals. HSD contributes to salt-sensitive hypertension. Traditional view on blood pressure regulation 
was focused on the kidneys and ECV expansion secondary to body Na+ load. However, the latest data 
suggest that salt-sensitive hypertension does not primarily come about by volume-related mechanisms 
and other than the renal body fluid control must play an important role. Since Na+ accumulation in 
the body does not necessarily lead to expansion of the extracellular volume it is suggested that Na+ 
might be stored in an osmotically inactive form either as osmotically inactive Na+ storage in the skin 
and/or osmotically neutral Na+/K+ exchange in muscle. Hypertonicity in the skin interstitium compa-
red with blood and therefore osmotic stress may be a crucial cause of interstitial Na+ accumulation 
and hypertension development. Dietary salt loading increases osmotically inactive skin Na+ storage 
and polyanionic character of the skin, leading to local hypertonicity. The response to this hypertonic 
internal environment in the skin interstitium involves MPS-driven and TonEBP–VEGF-C–mediated 
hyperplasia of lymph capillaries and increased eNOS expression. A decreased osmotically inactive 
storage capacity for Na+ or reduced osmotically neutral Na+/K+ exchange may predispose to marked 
volume retention, and therefore to rise in blood pressure. 
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Hypertension contributes to increased morbidity and mortality due to increased 
risk of cardiovascular complications. Salt sensitivity indicates relationship between 
increasing salt intake and blood pressure and sensitivity to alterations in salt 
intake is variable among individuals.
Blood pressure depends on volume-dependent (extracellular fluid volume, 
ECV) and volume-independent (autonomic nervous system, vascular resistance) 
mechanisms. Traditional view on blood pressure regulation especially salt-
sensitive hypertension was focused on the kidney which controls total body Na+ 
and thereby extracellular volume. According to this view in a state of excessive 
salt intake the kidney prevents ECV expansion that could rise blood pressure 
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by rapid excess fluid and Na+ eliminating. However, increased blood pressure 
and therefore the ECV expansion caused by reduced renal function, encourages 
a pressure natriuresis that corrects the body fluid volume change. Hence, ECV 
homeostasis is maintained at the expense of hypertension [1, 2]. Mineralocorticoid 
model of hypertension with Na+ and water accumulation in the body also supports 
the renal-body fluid blood pressure regulation, since in positive Na+ and water 
balances increased blood pressure stimulates pressure natriuresis. Thus a new 
steady state in Na+ and water balance is achieved [3]. 
The currently favored a two-compartment model of fluid and electrolytes 
homeostasis relies on the notion that Na+ is restricted mainly to the extracellular 
and K+ to the intracellular fluid and as main osmotic cations hold water in the 
extracellular or intracellular space [4, 5]. The wide-spread concept underscores 
that extracellular body fluids which are represented as two distinct compartments, 
the interstitial and the intravascular spaces, are in equilibrium and interstitial 
Na+ is mobilized into the bloodstream for renal Na+ clearance [6, 7]. 
However, human Na+ balance studies and experimental data suggest that high 
dietary Na+ consumption with Na+ accumulation in the body does not necessarily 
lead to expansion of the extracellular volume [8, 9] and negative Na+ balance is 
not paralleled by volume losses [10]. This suggests that Na+ might be stored in an 
osmotically inactive form. Farber and Soberman [11] were the first who speculated 
that Na+ may be stored in an osmotically inactive form in “bone, cartilage, or 
connective tissue” or exchanged for some other intracellular cation. 
40 years later Titze et al. imply that salt-sensitive hypertension does not 
primarily come about by volume-related mechanisms and other than the renal 
body fluid feedback control must play an important role in volume and blood 
pressure homeostasis [12].
DOCA salt is a widely accepted model for salt-sensitive hypertension [13]. 
Deoxycorticosterone-acetate (DOCA) reduces renal Na+ excretion and increases 
total body sodium (TBNa+) and total body volume (TBW). Secondary suppression 
of renin–angiotensin–aldosterone system [14] stimulates secretion of natriuretic 
peptides [15] and alters pressure natriuresis [3] establishing a new steady state 
between Na+ intake and Na+ excretion at a new blood pressure level. The kidneys 
escape the mineralocorticoid effect, and further salt retention stops, although at 
the expense of increased blood pressure [16]. 
Titze at al. show [17] that in DOCA rats given 1% saline only 20% of Na+ 
accumulated is osmotic active and leads to water retention, whereas the rest is 
accumulated as water free by osmotically inactive Na+ storage and/or osmotically 
neutral Na+/K+ exchange. TBNa+ excess is not accompanied by corresponding 
TBW excess, thus water-free Na+ accumulation prevents the rats from higher 
rTBW increase. Salt-sensitive hypertension is due to an increased susceptibility 
of the cardiovascular system to increase blood pressure at a given total body 
water content. This volume sensitivity of the cardiovascular system is caused by 
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increased sympathetic nerve activity and therefore increased peripheral vascular 
resistance [18] rather than increased cardiac output.
Additionally it is suggested that the redistribution of body electrolytes and water 
are important in the pathogenesis of salt-sensitive hypertension and is indicated 
that skin is a place of osmotically inactive Na+ storage and muscle is a site where 
osmoltically neutral Na+/ K+ exchange takes place [19]. 
The skin contains a lot of interstitial glycosaminoglycans (GAGs), which are 
negatively charged polyanions that attract Na+ and repel Cl–. Recent data show 
that modification of the skin GAGs may play an important role in the regulation 
of osmotically inactive skin Na+ storage as an extrarenal regulatory mechanism. 
Dietary salt loading increases osmotically inactive skin Na+ storage and polyanionic 
character of the skin, leading to local hypertonicity [20]. Animals fed 8% NaCl 
diet or drink 1% NaCl have increased Na+ content in the skin compared with low 
salt controls. However, water-free Na+ retention is not paralleled by skin water 
accumulation or K+ loss [21] confirming that the skin serves as an osmotically 
inactive Na+ reservoir. Selective Na+ accumulation without a parallel Cl- increase 
fails to increase blood pressure [22, 23]. Rats receiving DOCA and 1% NaCl to 
drink compared to those with DOCA and drinking NaHCO3 have similar average 
Na+ retention, while higher mean arterial pressure. Skin Na+ retention in excess 
over water in both DOCA-NaCl and DOCA-NaHCO3 rats is paralleled by blood 
pressure increases, while plasma sodium concentrations are not changed [10]. 
Thus hypertonicity in the skin interstitium compared with blood and therefore 
osmotic stress may be a crucial cause of interstitial Na+ accumulation and 
hypertension development. 
Titze et al. also persuade that osmotically inactive Na+ storage and/or local 
hypertonicity with DOCA-NaCl is not restricted to the skin but may also occur 
inside the muscle cell. They have found an osmotically neutral Na+/K+ exchange 
in the skeletal muscles, as evidenced by an increased Na+ to water balance with 
concomitant decreases in the tissue K+-to-water ratio [10, 12, 17]. Osmotically 
neutral Na+/K+ exchange challenges the view that Na+ retention is restricted to 
the extracellular fluid volume. 
Titze, thus, suggests three distinct regulatory levels that contribute to salt-
sensitive hypertension: “(1) Na+ balance sensitivity, which underscores the kidney’s 
role in the maintenance of TBNa+ homeostasis; (2) osmosensitivity, which determines 
whether or not a retained Na+ load exerts osmotic activity and, hence, increases 
ECV; and (3) volume sensitivity, which indicates the cardiovascular susceptibility 
to generate blood pressure at a given total body water content. These regulatory 
levels contribute individually to DOCA salt hypertension when the rats are fed 
a high-salt diet” [12]. 
Basing on findings from experiments with Dahl rats [24] or the rats with 
ovariectomy (OVX) [12] researchers speculate that a decreased osmotically inactive 
storage capacity for Na+ or reduced osmotically neutral Na+/K+ exchange may 
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predispose to marked volume retention, and therefore to the development of 
hypertension. High salt diet leads to Na+ retention in salt-sensitive (SS) but not 
in salt-resistant (SR) Dahl rats. Both SS and SR strains have impaired storage of 
osmotically inactive Na+ and SS rats are additionally characterized by a reduced 
ability to excrete Na+ loads, with Na+ accumulation and hypertension. Compared 
with DOCA salt rats, DOCA-OVX salt rats have higher blood pressure although Na+ 
retention (balance sensitivity) and the blood pressure-volume association (volume 
sensitivity) does not differ between these groups. The major difference between 
DOCA salt rats and DOCA-OVX salt rats is at the level of osmosensitivity. OVX 
reduces the osmotically inactive Na+ storage capacity, which increases volume 
retention despite similar Na+ retention. An impairment in Na+ accumulation in 
abundance over water goes along with further blood pressure rise in OVX-DOCA-
salt-treated rats.
The latest data provide new insights into mononuclear phagocyte system 
(MPS) cell and lymphatic function in pathogenesis of salt-sensitive hypertension. 
Na+-mediated osmotic differences between the interstitial fluid, the lymphatic 
environment and plasma stimulate macrophages in the skin interstitium to 
activate tonicity-responsive enhancer binding protein (TonEBP) [25]. TonEBP, an 
osmoprotective transcription factor, binds to the vascular endothelial growth factor 
C (VEGF-C) gene leading to hyperplasia of the lymph capillries in the interstitium 
and increased endothelial NO synthase (eNOS) expression in interstitial cells [26]. 
Inhibition of these processes by macrophage depletion or by blocking VEGF-C 
activity augments salt-sensitive hypertension, suggesting that MPS cells provide 
a buffering exrarenal mechanism for hypertension [27]. Different subtypes of 
MPS cells can evoke either proatherogenic (M1 subtypes) or antiatherogenic 
(M2 subtypes) effects [28]. MPS cells involved in regulation of volume and blood 
pressure homeostasis might represent an “M2 feature” and interstitial MPS 
infiltration may provide a protective effect against hypertension-induced target 
organ damage [27]. 
This article reviews the results and new theories concerning salt-sensitive 
hypertension from the studies performed by the group of Jens Titze from Erlangen-
Nürnberg, Germany.
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